Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 28,698 shares at $30.77 ($883K) on 2024-12-04, disclosed to the SEC on 2024-12-04.
Scheduled sale ($883k) by EVP R&D, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.77 | 14,349 | $442K | 50.0% |
| 2 | $30.77 | 14,349 | $442K | 50.0% |
| Total | $30.77 avg | 28,698 | $883K | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |